Tscan therapeutics to participate in the 2022 jefferies healthcare conference

Waltham, mass., june 02, 2022 (globe newswire) -- tscan therapeutics, inc. (nasdaq: tcrx), a clinical-stage biopharmaceutical company focused on the development of t-cell receptor (tcr) engineered t cell therapies (tcr-t) for the treatment of patients with cancer, today announced that management will participate in a fireside chat at the 2022 jefferies healthcare conference being held at the marriott marquis in new york, ny on thursday, june 9, 2022 at 9:30 a.m. et.
TCRX Ratings Summary
TCRX Quant Ranking